STREAMEX CORP. Related Party Transaction, Expenses from Transactions with Related Party
STREAMEX CORP. (STEX) reported Related Party Transaction, Expenses from Transactions with Related Party of $45.00 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty · last filed 2021-08-11
- STREAMEX CORP. related party transaction, expenses from transactions with related party for the quarter ending 2021-06-30 was $45.00K, a 37.93% decline year-over-year.
- STREAMEX CORP. related party transaction, expenses from transactions with related party for the quarter ending 2021-03-31 was $45.00K, a 40.00% decline year-over-year.
- STREAMEX CORP. related party transaction, expenses from transactions with related party for the quarter ending 2020-12-31 was $45.00K, a 16.71% decline year-over-year.
- STREAMEX CORP. related party transaction, expenses from transactions with related party for the quarter ending 2020-09-30 was $67.50K, a 10.00% decline year-over-year.
- STREAMEX CORP. related party transaction, expenses from transactions with related party for fiscal 2020 was $266.86K, a 4.36% decline from fiscal 2019.
- STREAMEX CORP. related party transaction, expenses from transactions with related party for fiscal 2019 was $279.03K.
| Period end | Related Party Transaction, Expenses from Transactions with Related Party 3 month | Related Party Transaction, Expenses from Transactions with Related Party 6 month | Related Party Transaction, Expenses from Transactions with Related Party 9 month | Related Party Transaction, Expenses from Transactions with Related Party 12 month |
|---|---|---|---|---|
| 2021-06-30 | $45.00K 10-Q · filed 2021-08-11 | $90.00K 10-Q · filed 2021-08-11 | $135.00K derived: sum of 3 quarters · filed 2021-08-11 | $202.50K derived: sum of 4 quarters · filed 2021-08-11 |
| 2021-03-31 | $45.00K 10-Q · filed 2021-05-17 | $90.00K derived: sum of 2 quarters · filed 2021-05-17 | $157.50K derived: sum of 3 quarters · filed 2021-05-17 | $230.00K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $112.50K derived: sum of 2 quarters · filed 2021-03-15 | $185.00K derived: sum of 3 quarters · filed 2021-08-11 | $266.86K 10-K · filed 2021-03-15 |
| 2020-09-30 | $67.50K 10-Q · filed 2020-11-05 | $140.00K derived: sum of 2 quarters · filed 2021-08-11 | $221.86K 10-Q · filed 2020-11-05 | $269.03K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-06-30 | $72.50K 10-Q · filed 2021-08-11 | $147.50K 10-Q · filed 2021-08-11 | $201.53K derived: sum of 3 quarters · filed 2021-08-11 | $276.53K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $75.00K 10-Q · filed 2021-05-17 | $129.03K derived: sum of 2 quarters · filed 2021-05-17 | $204.03K derived: sum of 3 quarters · filed 2021-05-17 | $279.03K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $54.03K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $129.03K derived: sum of 2 quarters · filed 2021-03-15 | $204.03K derived: sum of 3 quarters · filed 2021-03-15 | $279.03K 10-K · filed 2021-03-15 |
| 2019-09-30 | $75.00K 10-Q · filed 2020-11-05 | $150.00K derived: sum of 2 quarters · filed 2020-11-05 | $225.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $75.00K 10-Q · filed 2020-08-06 | $150.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $75.00K 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |